# NOVADIP Biosciences S.A.: Research, Mont-Saint-Guibert, Belgium

> NOVADIP Biosciences S.A.: NOVADIP Biosciences S.A. Based in Mont-Saint-Guibert, Belgium. Founded 2013.

Source: https://millionrounds.com/startup/novadip-biosciences-s-a (Millionrounds; every figure on the page links to its filing or article)

Belgium · [Research startup](https://millionrounds.com/companies)

# NOVADIP Biosciences S.A.

NOVADIP Biosciences S.A.

Email

Funding reported Last round: Series B

Research Mont-Saint-Guibert, Belgium

Follow NOVADIP Biosciences S.A. and see its new rounds in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Fstartup%2Fnovadip-biosciences-s-a)

Company summary

- **Founded:** 2013 13 years old
- **Team:** 58 51 to 200 people
- **Funding reported:** 87M as listed, currency not stated
- **Last round:** Series B Nov 2022

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for NOVADIP Biosciences S.A. has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About NOVADIP Biosciences S.A.

NOVADIP Biosciences S.A.

is a clinical-stage biopharmaceutical company based in Mont-Saint-Guibert, Belgium, founded in 2013. The company focuses on developing regenerative tissue products aimed at accelerating the healing of large bone defects, bone non-union, and spine fusion. Their mission is to create innovative solutions for patients with significant unmet medical needs, particularly those with limited treatment options. The company utilizes its proprietary 3M3 tissue regeneration technology platform, which employs adipose-derived stem cells to deliver growth factors and miRNAs that mimic natural physiology for tissue regeneration. NOVADIP is currently advancing two lead products in clinical trials: NVD-003, an autologous cell-based therapy for bone non-union and pediatric orthopedic conditions, and NVD-X3, an allogeneic bone grafting material designed for trauma surgery and spine fusion. With a dedicated team of approximately 45 staff members, NOVADIP is committed to improving patient outcomes in regenerative medicine.

## What company datasets say NOVADIP Biosciences S.A. raised

Funding, as reported

Reported in all **87M** in the source's currency

Rounds **4**

Last round **Series B**

Last round size **26.4M**

Last round date **Nov 2022**

Investors listed **12**

## On 3 portfolio pages

Investors who name them

- [Fund+](https://millionrounds.com/fund/fundplus)
- [New Science Venture](https://millionrounds.com/fund/new-science-ventures)
- [Epimède](https://millionrounds.com/fund/epimede)

Each firm lists NOVADIP Biosciences S.A. on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## The company, in detail

What they build

Known for

health care biotechnology research mirna critical size bone defects 3m 3 platform bone non-union stem cells hospital & health care medical bone grafting procedures extracellular matrix health biotechnology growth factors medical devices microrna/exosome therapeutics

Built with from their website

Google Tag Manager WordPress.org OVHcloud YouTube Viewport Meta Excel4Apps Babel Google Font API Microsoft Exchange MySQL

+8 more

PrimeNG Microsoft 365 Apps & Services Mobile Friendly Flywheel Gravatar Google Analytics Microsoft Sharepoint Divi

- **Sector:** Research
- **Industry code:** NAICS 33911, 541714, 325414, SIC 2834, 8731
- **Region:** Walloon Region
- **Revenue:** 3M a year, as listed
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/novadip-biosciences)

## Research in Belgium

Startups like it

- [**Fyteko** Anderlecht · founded 2014 *Raised*](https://millionrounds.com/company/fyteko)
- [**Cellaïon** Mont-Saint-Guibert · founded 2021](https://millionrounds.com/startup/cella-on)
- [**Precirix** Jette · founded 2014](https://millionrounds.com/startup/precirix)
- [**Full-Life Technologies** Gembloux · founded 2021](https://millionrounds.com/startup/full-life-technologies)
- [**Augustine Therapeutics** Leuven · founded 2019](https://millionrounds.com/startup/augustine-therapeutics)
- [**EyeD Pharma** Seraing · founded 2012](https://millionrounds.com/startup/eyed-pharma)
- [**atbtherapeutics** Marche-en-Famenne · founded 2018](https://millionrounds.com/startup/atbtherapeutics)
- [**Imcyse SA** Liege · founded 2011](https://millionrounds.com/startup/imcyse-sa)

## Is this your company?

Add your raise, your deck and your story, and put NOVADIP Biosciences S.A. in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)